# KM04 Preference Label 1 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task 042j9681, batch 20260608_174101).
Current status: DRAFT for platform entry.

Studio-selected pair:
- Transcript A = 0.400 (bundle 0fc9258f-2eb2-45b3-9130-228a56f03d59), 58 steps, 11m 3s.
- Transcript B = 0.350 (bundle d7256e11-3e29-4378-9898-e98ef75ffc21), 50 steps, 10m 23s.

Both deliverables read in full against golden-KM04-v2.docx and grader-guidelines-task4-v2.txt before labeling.

KEY FINDING: Both attempts propagated the central anemia/iron fabrication from the draft. Neither caught that no inpatient iron studies were obtained. However, B's propagation is more severe: it explicitly asserts "iron studies this admission were within target and hemoglobin is stable at goal," directly fabricating a lab result. A says only "no additional hematologic workup or separate follow-up is indicated," which propagates the closure but does not directly assert a fabricated study result. Both correctly handled prednisone (no numeric dose), CPAP (variable adherence), cardiorenal agents (held/staged), and pending logistics. The gap is severity of the central fabrication.

VERDICT: A1 (A slightly better). Button = plain "A" (no plus signs).

## Justification

Preferred output: A

A is slightly preferred over B. Both attempts propagated the central anemia-of-CKD fabrication from the draft, failing to identify that no inpatient iron studies were obtained and that anemia should remain an open outpatient item. However, the severity of propagation differs: B explicitly states "iron studies this admission were within target and hemoglobin is stable at goal; anemia is adequately managed on ferrous sulfate, with no additional hematologic workup or follow-up indicated," directly fabricating a specific lab result that does not exist in the chart. A states only "no additional hematologic workup or separate follow-up is indicated" without asserting that iron studies were obtained or at target. Both are incorrect on the central mechanism, but B manufactures a more explicit false claim.

Justification: The grader's Section C identifies the central scored failure as carrying the draft's claim that iron studies were at target forward as fact, when the chart contains no inpatient iron studies. B does exactly this in the most explicit form possible, directly stating fabricated lab findings. A's version is a softer propagation that implies closure without fabricating specific results. Outside the central mechanism, both attempts are clinically sound: both correctly withhold a numeric prednisone dose, keep cardiorenal agents held with staged outpatient restart, handle CPAP as variable adherence without unsupported claims, and preserve pending logistics as pending. The difference is the explicitness of the central fabrication.

Prompt adherence: Both deliver a finalized interdisciplinary care plan covering all domains the prompt asks for and completing the draft into a chart-ready document. Both are structured, physician-facing, and usable for the care team. This dimension is a tie.

Correctness: Both are incorrect on the central mechanism (anemia propagation). B is more incorrect because it fabricates a specific false result ("iron studies this admission were within target"), while A implies closure without inventing a specific finding. On all other axes (prednisone, cardiorenal restart, CPAP, antibiotics, functional status, pending logistics), both are accurate against the chart. The correctness gap is confined to the severity of the central fabrication.

Completeness: Both cover the required domains: infection and antibiotic course, cardiorenal protective agents with staged restart, glycemic management, PMR/steroid safety, functional and cognitive status, family supervision, OSA, and discharge logistics with follow-up. Both include a pre-discharge checklist of items to confirm. No material domain is missing from either.

Methodology: Both systematically reviewed the chart and verified claims against source documents for the non-anemia domains. Both failed to verify the anemia claim against the source record - neither identified that no inpatient iron studies exist in the 26-file chart. A's failure is passively carrying the draft's implication forward; B's failure is actively restating the fabricated finding as a specific clinical result.

Quality and clarity: Both are well-organized, physician-facing care-plan documents with appropriate structure. A is slightly longer (11,301 chars vs 10,283) but both are clearly written. The register and formatting are comparable. This dimension does not materially separate them.

Summary: A is preferred because, while both propagated the central anemia fabrication, B's propagation is more severe (explicitly stating "iron studies this admission were within target" as a fabricated lab result), whereas A implies closure without manufacturing specific findings. Both are otherwise clinically sound on all other domains. The difference is the explicitness of the central error, which is why this is a slightly-better A1 rather than a wider gap.

## Guardrails (must survive any edit)
1. Both propagated the central failure - do not claim either caught the anemia plant.
2. The distinction is severity of fabrication, not presence vs absence of the error.
3. Strongest word for the gap stays "slightly" - this is A1, not A2 (both failed).
4. Per Abi 6/7: this is PL 1 of 3 required for KM04; two more on different trajectories needed.

## Submit mechanics
Select plain A -> paste justification (from "Preferred output: A" through "Summary" section) into Comments -> Submit Preference -> confirm entry shows in submission history -> run Preference Labels AutoQC.
